ArticleFrontiers in oncology2022

Low-dose PD-1 inhibitor combined with lenvatinib for preemptive treatment of recurrence after liver transplantation for hepatocellular carcinoma: Case report and literature review.

Xin Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.